Latest Videos |view all videos
Transplant immunology and HLA testing
Mohamed Elrefaei, M.D., Ph.D., director of the Histocompatibility Laboratory at Mayo Clinic and assistant professor of laboratory medicine and pathology at Mayo Clinic College of Medicine and Science, discusses transplant immunology as ...
Is sirolimus the superior heart transplant anti-rejection therapy?
Mayo Clinic cardiologist and transplant specialist Sudhir S. Kushwaha, M.D., discusses medications to improve heart transplant outcomes with Mayo Clinic heart transplant medical director Alfredo L. Clavell, M.D., in this video first shown ...
Optimal liver transplant care at Mayo Clinic's campus in Jacksonville, Florida
About 13,000 people in the United States are waiting for a liver on the national transplant waitlist. The Liver Transplant Program at Mayo Clinic's campus in Jacksonville, Florida, uses a unique multidisciplinary team approach to address this need.
A new future for cystic fibrosis
Cystic fibrosis is one of the most common genetically transmitted diseases, causing repeated infections that lead to lung failure.
Double impact: Pioneering simultaneous liver transplant and gastric sleeve resection
Liver failure associated with obesity is on the rise in the United States.
Survival of diabetes and nondiabetes kidney transplant patients — Mayo Clinic
Mayo Clinic researchers have discovered that the five-year survival of diabetic kidney transplant patients is now on par with the five-year survival of nondiabetic kidney recipients.
Modern treatment for polycystic kidney disease
Mikel Prieto, M.D., a transplant surgeon at Mayo Clinic's campus in Minnesota, discusses a landmark case that set a new standard of care for operating on patients with polycystic kidney disease.
Cellular therapy for liver disease
Robert C. Huebert, M.D., and Jorge Rakela, M.D., discuss their article appearing in the March 2014 issue of Mayo Clinic Proceedings.